Premium
P4‐354: Baseline CSF BETA‐AMYLOID 42 correlates with ApoE genotype and baseline cognitive status in a phase II avagacestat predementia Alzheimer's disease study
Author(s) -
Soares Holly,
Berisha Flora,
Gleason Carol,
Green George,
Tiller Jane,
Piccoli Stephen,
Burns Leah,
Berman Robert,
Kaplita Stephen,
Coric Vlad
Publication year - 2012
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2013.08.135
Subject(s) - medicine , biomarker , tolerability , dementia , apolipoprotein e , cognitive decline , oncology , effects of sleep deprivation on cognitive performance , cerebrospinal fluid , alzheimer's disease , psychology , disease , cognition , psychiatry , biology , adverse effect , biochemistry